Urology News and Research

Latest Urology News and Research

Watson Pharmaceuticals signs exclusive, worldwide licensing agreement with Itero Biopharmaceuticals

Watson Pharmaceuticals, Inc. today announced an exclusive, worldwide licensing agreement with Itero Biopharmaceuticals, Inc., a venture-backed specialty biopharmaceutical company, to develop and commercialize Itero's Recombinant Follicle Stimulating Hormone. The product is currently in preclinical development as a biosimilar molecule for the treatment of female infertility.

15 Jul 2010

St. Luke's Episcopal Hospital ranked among America's elite healthcare institutions

In its annual survey of "America's Best Hospitals," U.S. News & World Report has ranked St. Luke's Episcopal Hospital (SLEH) among the elite healthcare institutions in the nation in five major areas of care. This includes the Texas Heart® Institute (THI) at St. Luke's Episcopal Hospital, listed in the top ten nationally in heart and heart surgery for the 20th consecutive year.

15 Jul 2010

New Cystex Liquid Cranberry Complex with Proantinox reduces incidence of UTIs in women: Study

A new study being published in the journal Urology shows that Proantinox, a proprietary cranberry-based blend used successfully in hospitals and long-term care facilities as UTI-Stat, and now available directly to consumers as new Cystex Liquid Cranberry Complex with Proantinox, is safe and effective in significantly reducing the incidence of UTIs in women at risk for recurring infections.

15 Jul 2010

AMS reports positive results from clinical trial of MiniArc Single-Incision Sling System for SUI

American Medical Systems® (AMS), a leading provider of world-class devices and therapies for both male and female pelvic health, today announced results of a prospective, multi-center study on their market leading MiniArc Single-Incision Sling System for female stress urinary incontinence (SUI). The study concludes that MiniArc efficacy rates for negative cough stress test (CST) and 1-hr Pad Weight Test (PWT) at 12 months were 90.6 percent and 84.5 percent, respectively.

15 Jul 2010

Study links high-fat diet as potential cause of prostatic diseases

Prostate cancer is the second leading cause of cancer-related deaths in men with an estimated 192,280 new cases diagnosed in the US in 2009 (Jemal 2009). Diet is considered one of the most important controllable risk factors for inflammation and prostate diseases including benign prostatic hyperplsia, prostatitis, and prostate cancer.

15 Jul 2010

Mylan to acquire Bioniche Pharma for $550M

Mylan Inc. today announced plans to acquire Bioniche Pharma Holdings Limited, a privately held, global injectable pharmaceutical company for $550 million in cash. Bioniche Pharma will provide Mylan not only an immediate entry into the North American injectables market but also a platform for future growth opportunities. This transaction is expected to be accretive to Mylan's earnings in year one, without accounting for any operational or other synergies.

15 Jul 2010

U-M Hospitals and Health Centers ranked 14th among America's best hospitals

The University of Michigan Hospitals and Health Centers have been ranked among the country's best hospitals, placing 14th overall for the second consecutive year by U.S. News & World Report magazine. This year, U-M was ranked in every specialty and those rankings went up in 11 of the 16 specialties.

15 Jul 2010

Diet and exercise can reduce severity of hot flashes in overweight, obese women

A new study shows that overweight and obese women who suffer from hot flashes can reduce the severity of their hot flashes if they lose weight through diet or exercise.

14 Jul 2010

Oncura signs distribution agreement with Theragenics for palladium-103 brachytherapy seeds

ONCURA, a business unit of GE Healthcare and global leader in the minimally invasive permanent prostate brachytherapy management of prostate cancer, has announced that it has signed an agreement to distribute Theragenics Corporation TheraSeed(R) palladium-103 brachytherapy seeds.

14 Jul 2010

Drugs taken for common medical conditions cause long term cognitive impairment in older adults: Study

Drugs commonly taken for a variety of common medical conditions including insomnia, allergies, or incontinence negatively affect the brain causing long term cognitive impairment in older African-Americans, according to a study appearing in the July 13, 2010 print issue of Neurology, the medical journal of the American Academy of Neurology.

14 Jul 2010

Researchers investigate oral cancer, periodontal disease relationship

Today during the 88th General Session & Exhibition of the International Association for Dental Research, in Barcelona, Spain, presenting author J. Meyle, Justus Liebig University, Giessen, Germany, will present an abstract titled "P. gingivalis Infection and Immune Evasion of Oral Carcinomas."

14 Jul 2010

Watson Laboratories files ANDA with FDA for generic Renvela for oral suspension

Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration seeking approval to market sevelamer carbonate for oral suspension, 0.8g and 2.4g per packet. Watson's sevelamer carbonate for oral suspension product is the generic version of Genzyme's Renvela for Oral Suspension.

13 Jul 2010

Theragenics signs supply agreement with Oncura for TheraSeed palladium-103 brachytherapy seeds

Theragenics Corporation, a medical device company serving the surgical products and prostate cancer treatment markets, today announced that it has signed an agreement with Oncura, Inc. for the distribution of TheraSeed® palladium-103 brachytherapy seeds. Oncura is a unit of GE Healthcare. Under the terms of the agreement, Theragenics will be the exclusive palladium-103 seed supplier to Oncura, subject to certain pre-existing vendor agreements, for the treatment of prostate cancer in the U.S. and Canada.

12 Jul 2010

BCAN to celebrate first annual Bladder Cancer Awareness Day

The Bladder Cancer Advocacy Network will celebrate the first annual Bladder Cancer Awareness Day on Saturday, July 17 with more than two dozen volunteer-led events nationwide. In addition to raising public awareness about the risks and signs of bladder cancer, the events will serve as a forum for bladder cancer patients, survivors and their caregivers to meet and share their stories.

12 Jul 2010

Men with higher baseline PSA value more likely to die from prostate cancer, say researchers

Men who have a baseline PSA value of 10 or higher the first time they are tested are up to 11 times more likely to die from prostate cancer than are men with lower initial values, according to Duke University Medical Center researchers.

9 Jul 2010

Scientists shrink distant sarcomas with genetically reprogrammed herpes virus and anti-vascular drug

Scientists have used a genetically reprogrammed herpes virus and an anti-vascular drug to shrink spreading distant sarcomas designed to model metastatic disease in mice – still an elusive goal when treating humans with cancer, according to a study in the July 8 Gene Therapy.

8 Jul 2010

Children of unemployed Americans experience avoidable loss of healthcare coverage: Research

Not only are the children of the 15.3 million unemployed Americans feeling the impact of financial hardship brought on by the economic recession, many of their children may be experiencing an avoidable loss of healthcare coverage, according to new research by the Child Policy Research Center at Cincinnati Children's Hospital Medical Center published in the July issue of Health Affairs.

8 Jul 2010

Ethicon launches OMNEX Surgical synthetic sealant

Ethicon, Inc., a worldwide leader in surgical care, announced today the introduction of ETHICON™ OMNEX™ Surgical Sealant, ETHICON™ Biosurgery's first synthetic sealant designed to achieve adjunctive hemostasis (stoppage of bleeding) in vascular reconstructions by mechanically sealing areas of leakage. The US Food and Drug Administration (FDA) recently granted approval of the Premarket Approval Application (PMA) for ETHICON™ OMNEX™ Surgical Sealant.

8 Jul 2010

Scientists use genetically reprogrammed herpes virus to shrink distant sarcomas

Scientists have used a genetically reprogrammed herpes virus and an anti-vascular drug to shrink spreading distant sarcomas designed to model metastatic disease in mice - still an elusive goal when treating humans with cancer, according to a study in the July 8 Gene Therapy.

8 Jul 2010

BCAN applauds Representative Rooney for resolution to recognize National Bladder Cancer Awareness Day

The Bladder Cancer Advocacy Network (BCAN), the first national advocacy organization dedicated to improving public awareness of bladder cancer, applauds U.S. Representative Tom Rooney (R-Fla.) for introducing a resolution to recognize July 17, 2010 as "National Bladder Cancer Awareness Day."

7 Jul 2010

Urology News and Research

Latest Urology News and Research

Watson Pharmaceuticals signs exclusive, worldwide licensing agreement with Itero Biopharmaceuticals

St. Luke's Episcopal Hospital ranked among America's elite healthcare institutions

New Cystex Liquid Cranberry Complex with Proantinox reduces incidence of UTIs in women: Study

AMS reports positive results from clinical trial of MiniArc Single-Incision Sling System for SUI

Study links high-fat diet as potential cause of prostatic diseases

Mylan to acquire Bioniche Pharma for $550M

U-M Hospitals and Health Centers ranked 14th among America's best hospitals

Diet and exercise can reduce severity of hot flashes in overweight, obese women

Oncura signs distribution agreement with Theragenics for palladium-103 brachytherapy seeds

Drugs taken for common medical conditions cause long term cognitive impairment in older adults: Study

Researchers investigate oral cancer, periodontal disease relationship

Watson Laboratories files ANDA with FDA for generic Renvela for oral suspension

Theragenics signs supply agreement with Oncura for TheraSeed palladium-103 brachytherapy seeds

BCAN to celebrate first annual Bladder Cancer Awareness Day

Men with higher baseline PSA value more likely to die from prostate cancer, say researchers

Scientists shrink distant sarcomas with genetically reprogrammed herpes virus and anti-vascular drug

Children of unemployed Americans experience avoidable loss of healthcare coverage: Research

Ethicon launches OMNEX Surgical synthetic sealant

Scientists use genetically reprogrammed herpes virus to shrink distant sarcomas

BCAN applauds Representative Rooney for resolution to recognize National Bladder Cancer Awareness Day

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Urology News and Research

Latest Urology News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in